LIMR hosted several notable speakers, including several from Thomas Jefferson University, University of Pennsylvania, Geisinger, as well as from other regions of the country and even from abroad.

2018 notable speakers

Ursula Grohmann, PhD, professor of pharmacology, University of Perugia, Italy. Topic: Evolutionary dynamics as drug target in autoimmunity and neoplasia.

Gabriel Chodick, PhD, head of epidemiology and database research, Maccabi Healthcare Services, Israel. Topic: Big data for health care quality, research and innovation in a not-for-profit provider in Israel.

Katherine Nathanson, MD, Perelman School of Medicine, University of Pennsylvania. Topic: Everything old is new again: novel findings in BRCA1/2 associated tumors.

Mauricio Reginato, PhD, professor, Department of Biochemistry and Molecular Biology, and director of the Graduate Program in Cancer Biology at Drexel University College of Medicine. Topic: Glycosylation: linking signaling and metabolism in cancer and beyond.

Andrew E. Aplin, PhD, associate director for basic research and Program Leader for Cancer Cell Biology and Signaling, Sidney Kimmel Cancer Center, Thomas Jefferson University. Topic: Optimizing the use of targeted inhibitors in melanoma.

Maureen Murphy, PhD, professor and program leader, Molecular and Cellular Oncogenesis Program, Wistar Institute. Topic: Tumor suppressor mutations in cancer.

Brent Williams, PhD, research investigator at the Center for Health Research, Geisinger. Topic: Using electronic medical records for research: early lessons and practical advice.

Barbara Vilen, PhD, associate professor, Department of Microbiology and Immunology, University of North Carolina School of Medicine. Topic: Dying cells, lysosome dysfunction and lupus.

Jim Shorter, PhD, associate professor of biochemistry and biophysics, Perelman School of Medicine, University of Pennsylvania. Topic: Reversing aberrant phase transitions connected with ALS/FTD.

Daniel P. Silver, MD, PhD, director of basic science and research in Medical Oncology at Thomas Jefferson University. Topic: MECP2 is a frequently amplified oncogene with a novel epigenetic mechanism of action.

Jennifer Johnson, MD, PhD, associate professor, Thomas Jefferson University. Topic: Immunotherapy in head and neck cancer: clinical trials in early and locally advanced disease.

Lorenzo Galluzzi, PhD, assistant professor, Department of Radiation Oncology, Weill Cornell Medical College, New York. Topic: Cell stress, survival and death in cancer therapy.

Priya Mammen, MD, MPH, clinical associate professor and director of public health programs in the Department of Emergency Medicine, Sidney Kimmel Cancer Center, Thomas Jefferson University. Topic: Role of the emergency department in addressing public health issues: lessons from the Emergency Opt-out Program.

Jennifer K. Wagner, JD, PhD, associate director of bioethics research, Geisinger. Topic: Health care delivery for trafficked patients in Pennsylvania.

Jordan Winter, MD, chief of surgical oncology and director of surgical services, Seidman Cancer Center. Topic: Pancreatic cancer-associated depression and the role of IDO.

Laurie Kilpatrick, PhD, professor, Center for Inflammation, Translational and Clinical Lung Research, Lewis Katz School of Medicine, Temple University. Topic: Protein kinase C-delta: a novel therapeutic target in sepsis.